Identification of potential biomarkers in the peripheral blood of neonates with bronchopulmonary dysplasia using WGCNA and machine learning algorithms

Liyan Luo,Fei Luo,Chuyan Wu,Hong Zhang,Qiaozhi Jiang,Sixiang He,Weibi Li,Wenlong Zhang,Yurong Cheng,Pengcheng Yang,Zhenghu Li,Min Li,Yunlei Bao,Feng Jiang
DOI: https://doi.org/10.1097/md.0000000000037083
IF: 1.6
2024-02-03
Medicine
Abstract:Bronchopulmonary dysplasia (BPD) is a prevalent and complicated neonatal condition, with its incidence rates continuing to rise. [ 1 ] In Europe and the US, approximately 28,000 and 18,000 babies, respectively, are affected by this condition every year. [ 2 , 3 ] Premature infants who develop BPD often experience long-term respiratory and neurodevelopmental complications. [ 4 ] The primary pathological alterations observed in individuals with BPD are simplified alveolar structures and pulmonary capillary dysplasia. In immature lungs, lung damage may result from a variety of factors, such as barotrauma, volutrauma, oxygen toxicity, fluid overload, genetic predispositions, infections, and inflammatory responses. [ 5 , 6 ] Despite extensive research, the intricate etiology and complex pathogenesis of BPD pose significant challenges in identifying specific biomarkers for its accurate prediction and effective treatment. [ 7 ]
medicine, general & internal
What problem does this paper attempt to address?